List Abbreviation | List Type | | List Category | Green Screen Hazard | Green Screen Benchmark |
NIOSH | Authoritative | A | Occupational Cancer | H | 1 |
NTP-C | Authoritative | A | Known to be a human carcinogen | H | 1 |
NTP-C | Authoritative | A | Reasonably Anticipated to be a human carcinogen | H | 1 |
NTP-C | Authoritative | A | Chemicals of high concern | H | 1 |
SVHC | Authoritative | A | Extremely Hazardous Substance, may be Green Screen vH or H | vH | 1 |
IRIS (1999, 2005) | Authoritative | A | Carcinogenic to humans | H | 1 |
IRIS (1999, 2005) | Authoritative | A | Likely to be carcinogenic to humans | H | 1 |
IRIS (2005) | Authoritative | B | Suggestive evidence of carcinogenic potential | M | 2 |
IRIS (1999, 2005) | Authoritative | A | Not likely to be carcinogenic to humans | L | N/A |
IRIS (1999) | Authoritative | B | Suggestive evidence of carcinogenicity, but not sufficient to assess human carcinogenic potential | M | 2 |
IRIS (1996) | Authoritative | A | Known/likely human carcinogen | H | 1 |
IRIS (1986) | Authoritative | A | Group A - Human Carcinogen | H | 1 |
IRIS (1986) | Authoritative | A | Group B1 - Probably human carcinogen | H | 1 |
IRIS (1986) | Authoritative | A | Group B2 - Probably human carcinogen | H | 1 |
IRIS (1986) | Authoritative | B | Group C - “Possible human carcinogen” | M | 2 |
IRIS (1986) | Reference | | Group D – “Not classifiable as to human carcinogenicity”? (can be either not likely or a data gap) | Unknown | |
IRIS (1986) | Authoritative | A | Group E - “Evidence of non-carcinogenicity to humans” | L | N/A |
IARC | Authoritative | A | Group 1: Agent is carcinogenic to humans | H | 1 |
IARC | Authoritative | A | Group 2A: Agent is probably carcinogenic to humans | H | 1 |
IARC | Authoritative | B | Group 2b: Possibly carcinogenic to humans | M | 2 |
IARC | Reference | | Group 3: Not classifiable as to carcinogenicity to humans | Unknown | N/A |
IARC | Authoritative | A | Group 4: Probably not carcinogenic to humans | L | N/A |
PROP 65 | Authoritative | A | Known to the state to cause cancer | H | 1 |
PROP 65 | Authoritative | A | Known to the state to cause reproductive effects | H | 1 |
EU CMR List | Authoritative | A | Carcinogen Category 1: “known” | H | 1 |
EU CMR List | Authoritative | A | Carcinogen Category 2: “should be considered carcinogenic to humans” | H | 1 |
EU CMR List | Authoritative | B | Carcinogen Category 3: “possibly carcinogenic to humans” (listed as Carc. Cat. 3) | M | 2 |
EU CMR List | Authoritative | A | Mutagen Category 1: “Substances known to be mutagenic to man” | H | 1 |
EU CMR List | Authoritative | A | Mutagen Category 2: “Substances which should be regarded as if they are mutagenic to man” | H | 1 |
EU CMR List | Authoritative | B | Mutagen Category 3: Possible | M | 2 |
EU CMR List | Authoritative | A | Reproduction Category 1: “known” to impair fertility in humans or cause developmental toxicity in humans” | H | 1 |
EU CMR List | Authoritative | A | Reproduction Category 2: “should be regarded as if” they impair fertility to humans or cause developmental toxicity to humans” | H | 1 |
EU CMR List | Authoritative | B | Reproduction Category 3: possible | M | 2 |
G&L | Screening | A | Developmental Neurotoxicant | H | 1 |
G&L | Screening | A | Neurotoxicant | M | 2 |